Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease
- 1 August 2002
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 144 (2), 226-232
- https://doi.org/10.1067/mhj.2002.125513
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Determinants of mortality after myocardial infarction in patients with advanced renal dysfunctionAmerican Journal of Kidney Diseases, 2001
- Effect of Beta-Blockade on Mortality among High-Risk and Low-Risk Patients after Myocardial InfarctionNew England Journal of Medicine, 1998
- Acute Renal Failure After Coronary InterventionAmerican Journal Of Medicine, 1997
- Serum Creatinine Concentration and Risk of Cardiovascular DiseaseStroke, 1997
- Preoperative Renal Risk StratificationCirculation, 1997
- Predictability of creatinine clearance estimates in critically ill patientsCritical Care Medicine, 1993
- Cardiovascular disease risk profilesAmerican Heart Journal, 1991
- Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition.Journal of Clinical Investigation, 1987
- Bleeding time in Uremia: A useful test to assess clinical bleedingAmerican Journal of Hematology, 1979
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976